Explore how Genesis Therapeutics and NVIDIA are transforming drug discovery using AI technology. Discover their collaboration to accelerate the development of personalized medicines and improve therapeutic outcomes, revolutionizing the pharmaceutical landscape.
SEBI focuses on strengthening the startup ecosystem, by proposing the maximum investment limit by angel funds in a single startup to Rs 25 crore, up from the current limit of Rs 10 crore.
